Neurallys startup

Hydrocephalus is a pathology caused by an accumulation of cerebrospinal fuild within the brain and resulting in abnormal intracranial pressure. The most common treatment used today requires surgery to implant a shunt system. Neurallys is developing  a very innovative medical device to improve the quality of life of those patients and provide the neurosurgeons with a new tool for aided-diagnosis and pathology follow-up, with health cost reduction objectives.

Latest News

Neurallys, selected for the France Tech Transfer Invest 2018

Date: 09-02-2018

Neurallys, startup from the iPEPS-ICM incubator, will be attending the France Tech Transfer Invest 2018 as disruptive medtech company in the French ecosystem. This event presents annually the best 40 new tech spin-offs of France in the #digitaltech, #healthtech...

Read more